Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
- PMID: 25656486
- PMCID: PMC4323135
- DOI: 10.1186/s12879-015-0777-3
Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
Abstract
Background: Recent studies worldwide have reported increasing numbers of adults diagnosed with Bordetella pertussis despite receiving childhood vaccinations. This study describes a pertussis outbreak at a university medical faculty campus and examines the effectiveness of diphtheria, tetanus, and pertussis (DTaP) vaccination completed during infancy in Japan.
Methods: After the outbreak, self-administered questionnaires and serum samples were collected from students on campus to determine the incidence of pertussis and underlying diseases. Pertussis was diagnosed on the basis of clinical criteria and serum anti-pertussis toxin antibody levels. Using data collected from 248 first and second grade students who had submitted copies of their vaccination records, we evaluated the effectiveness of DTaP vaccination in infancy against adult pertussis.
Results: Questionnaire responses were obtained from 636 students (of 671 registered students; 95% response rate). Of 245 students who reported a continuous cough during the outbreak period, 84 (attack rate: 13.2%) were considered "probable" pertussis cases that met clinical criteria. The outbreak occurred mainly in first and second grade students in the Faculty of Medicine. Of 248 students who provided vaccination records, 225 had received 4 DTaP doses (coverage: 90.7%); the relative risk of the complete vaccination series compared to those with fewer than 4 doses or no doses for probable cases was 0.48 (95% confidence interval: 0.24-0.97).
Conclusions: Waning protection was suspected due to over time. Booster vaccination for teenagers and development of highly efficacious pertussis vaccines are needed.
Figures


Similar articles
-
Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine.Vaccine. 2016 May 11;34(22):2496-500. doi: 10.1016/j.vaccine.2016.03.083. Epub 2016 Mar 31. Vaccine. 2016. PMID: 27038131
-
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759. Pediatrics. 2005. PMID: 16061582
-
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34. MMWR Recomm Rep. 2006. PMID: 16557217
-
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Vaccine. 2012. PMID: 22709953 Review.
-
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Expert Rev Vaccines. 2008. PMID: 18564017 Review.
Cited by
-
Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia.Infect Dis Ther. 2021 Sep;10(3):1115-1140. doi: 10.1007/s40121-021-00439-1. Epub 2021 Apr 29. Infect Dis Ther. 2021. PMID: 33928533 Free PMC article. Review.
-
Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model.Vaccines (Basel). 2023 Apr 28;11(5):914. doi: 10.3390/vaccines11050914. Vaccines (Basel). 2023. PMID: 37243018 Free PMC article.
-
Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.Microb Genom. 2018 May;4(5):e000180. doi: 10.1099/mgen.0.000180. Epub 2018 May 17. Microb Genom. 2018. PMID: 29771235 Free PMC article.
-
Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.J Med Chem. 2015 Oct 8;58(19):7833-49. doi: 10.1021/acs.jmedchem.5b01087. Epub 2015 Sep 22. J Med Chem. 2015. PMID: 26351878 Free PMC article.
-
Alarm Thresholds for Pertussis Outbreaks in Iran: National Data Analysis.Osong Public Health Res Perspect. 2020 Oct;11(5):309-318. doi: 10.24171/j.phrp.2020.11.5.07. Osong Public Health Res Perspect. 2020. PMID: 33117636 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous